DGX logo

Quest Diagnostics Incorporated (DGX)

$256.35

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on DGX

Market cap

$28.20B

EPS

10.04

P/E ratio

24.5

Price to sales

2.21

Dividend yield

1.342%

Beta

0.546802

Price on DGX

Previous close

$262.21

Today's open

$260.65

Day's range

$256.09 - $262.94

52 week range

$171.18 - $263.19

Profile about DGX

CEO

James E. Davis

Employees

57000

Headquarters

Secaucus, NJ

Exchange

New York Stock Exchange

Shares outstanding

110019073

Issue type

Common Stock

DGX industries and sectors

Healthcare

Medical Diagnostics & Screening

News on DGX

Quest Diagnostics Incorporated (DGX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Quest Diagnostics Incorporated (DGX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Nov 17, 2026

news preview

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Nov 12, 2026

news preview

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on January 27, 2027, to shareholders of record of Quest Diagnostics common stock on January 12, 2027.

news source

PRNewsWire • Nov 10, 2026

news preview

Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference

SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference in Miami on Tuesday, December 1, 2026, at 2:10 p.m.

news source

PRNewsWire • Nov 9, 2026

news preview

Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London

SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 8:30 a.m.

news source

PRNewsWire • Nov 9, 2026

news preview

The big winners of the tech wreck are biopharma stocks

Who would have believed that the boring healthcare industry would be the hottest stock sector of 2026? Companies like Johnson & Johnson, Quest Diagnostics and UnitedHealth Group have long been known for producing steady results, driven by patient demand and government reimbursement.

news source

Market Watch • Oct 30, 2026

news preview

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Oct 27, 2026

news preview

Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update

The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exelixis rounded out our top contributors.

news source

Seeking Alpha • Oct 27, 2026

news preview

Quest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's

Quest Diagnostics is upgraded to a strong buy, driven by robust earnings momentum, sector resilience, and sustained outperformance versus benchmarks. DGX delivered its fourth consecutive earnings beat, with Q3 revenue up 10% YoY and EPS up 28.7%, prompting raised full-year guidance. Quest's competitive edge is reinforced by superior margins, a strong ROE above 15%, ongoing innovation, and an investment-grade balance sheet with declining leverage.

news source

Seeking Alpha • Oct 27, 2026

news preview

Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach

Medical lab testing giant Quest Diagnostics has confirmed a cyberattack and data breach affecting an as-yet unspecified amount of sensitive patient information stored in its systems, according to a legally required disclosure with U.S. regulators.

news source

TechCrunch • Oct 23, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Quest Diagnostics Incorporated

Open an M1 investment account to buy and sell Quest Diagnostics Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in DGX on M1